Drug-nutrient interactions in transplant recipients (Q34239257)

31 July 2017

1 reference

title

Drug-nutrient interactions in transplant recipients (English)

1 reference

31 July 2017

L N Chan

1

1 reference

31 July 2017

publication date

1 May 2001

1 reference

Journal of Parenteral and Enteral Nutrition

31 July 2017

published in

1 reference

31 July 2017

volume

25

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

132-141

1 reference

Influence of Food on the Bioavailability of Drugs

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0148607101025003132

Hyperammonemia and valproate-induced alterations of the state of consciousness. A report of 8 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607101025003132

Amelioration of adverse effects of valproic acid on ketogenesis and liver coenzyme A metabolism by cotreatment with pantothenate and carnitine in developing mice: possible clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607101025003132

Valproate induced encephalopathy treated with carnitine in an adult

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607101025003132

Hyperhomocyst(e)inemia and the increased risk of venous thromboembolism: more evidence from a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607101025003132

Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607101025003132

Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607101025003132

Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607101025003132

Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607101025003132

Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607101025003132

Enhanced reduction of fasting total homocysteine levels with supraphysiological versus standard multivitamin dose folic acid supplementation in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607101025003132

The effect of water-soluble vitamin E on cyclosporine pharmacokinetics in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607101025003132

The pharmacological role of P-glycoprotein in the intestinal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607101025003132

Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607101025003132

Grapefruit juice-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607101025003132

Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607101025003132

Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607101025003132

Influence of chronic ingestion of grapefruit juice on steady-state blood concentrations of cyclosporine A in renal transplant patients with stable graft function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607101025003132

Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607101025003132

The fate of naringin in humans: A key to grapefruit juice-drug interactions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607101025003132

Quercetin, an in vitro inhibitor of CYP3A, does not contribute to the interaction between nifedipine and grapefruit juice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607101025003132

Naringin and naringenin are not the primary CYP3A inhibitors in grapefruit juice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607101025003132

Grapefruit juice activates P-glycoprotein-mediated drug transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607101025003132

Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607101025003132

Effects of intestinal CYP3A4 and P-glycoprotein on oral drug absorption--theoretical approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607101025003132

Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607101025003132

10.1177/0148607101025003132

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference